Affygility Solutions’ President to present at High Potent Drugs 2013 Conference in Mumbai, India
- Understanding control banding systems for early stage compounds to evaluate and identify why these studies are critical
- Developing appropriate methodologies for identifying and categorizing pharmaceutical compounds to define specific process requirements
- Critically examining the current market dynamics and demand scenario for potent drugs in India to effectively capitalise on the future opportunities
- Outlining the proven and future advantages of Potent Drugs compared to conventional drugs
For further information about potent compound safety programs and occupational exposure control banding for pharmaceuticals, go to the Affygility Solutions website.